Longevity is a sizzling pattern in Silicon Valley nowadays, pushed by rising curiosity—particularly among the many rich—in stopping illness by common testing.
A brand new participant, Biograph, has simply emerged from stealth, and it’s co-founded by one of many greatest names in longevity science: Dr. Peter Attia. Attia is a Canadian-American doctor finest often known as the creator of the bestseller “Outlive: The Science and Art of Longevity” and for his podcast.
Biograph’s CEO and different co-founder is John Hering, a distinguished Silicon Valley determine. A cybersecurity founder who infamously scanned celebrities’ cellphones on the 2005 Academy Awards, Hering has grow to be finest often known as one Elon Musk’s greatest backers by his function as a associate at Vy Capital. There, Hering has poured billions into Musk’s startups and donated $500,000 to a pro-Trump tremendous PAC earlier than the election, per a WSJ profile.
Biograph calls itself the world’s “most superior” preventive well being and diagnostics clinic. It at the moment has a location in Silicon Valley with plans to open in New York City this quarter, and ultimately develop globally, in line with an announcement on its web site.
The startup says it is going to gather over 1,000 knowledge factors throughout 30+ evaluations to color a holistic image of somebody’s well being and optimize their lifespan. It doesn’t come low-cost: its Core membership prices $7,500 per 12 months whereas the premium Black membership—which it says gives the “deepest insights”—runs $15,000.
Biograph is backed by Vy Capital, Human Capital, Alpha Wave, and Wndr Co, together with angel buyers together with Balaji Srinivasan, the startup advised TechCrunch. Biograph declined to specify how a lot funding it has raised.
In a press release, Hering stated he was impressed to co-found Biograph by the most cancers prognosis of his Vy Capital associate and good friend Alexander Tamas. Tamas posted on X {that a} check-up in his late 30s resulted in an early thyroid most cancers prognosis that most likely saved his life—and induced him to encourage Hering to get checked, too.
Biograph claims that over 15% of members have reported discovering “pressing or life-alerting well being” insights by its providers. The firm has been quietly working since 2020, in line with the LinkedIn profile of its government medical director Michael Doney, a physician with a background in longevity.
While Biograph’s announcement doesn’t point out AI, the corporate is at the moment on the lookout for a founding AI engineer to construct an AI-powered assistant, in line with its careers web page.
Biograph is a part of a quiet growth in startups devoted to residing longer, with Andreessen Horowitz-backed Function Health searching for a $2 billion valuation this 12 months and Sam Altman-backed Retro Biosciences in talks to boost a cool $1 billion final month.
